SCHEMBL17065837

SCHEMBL17065837

CCN(CC)c1c(Br)ccc2cc(OC)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 4/20 0.42
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
CLK1 P49759 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 1/20 0.38
HTR2A P28223 1/20 0.38
NPC1 O15118 1/20 0.38
NSD2 O96028 1/20 0.38
S100A4 P26447 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17065824 0.75 CALM1 (0.43) MEN1KMT2ACYP1A2CYP2A6MAPK1
SCHEMBL15266968 0.74 CYP1A2 (0.48) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL5752191 0.74 CYP2A6 (0.48) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL5337507 0.72 TUBB4A (0.50) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL8589628 0.72 MTNR1A (0.48) KDM4EMEN1KMT2ACYP1A2L3MBTL1
SCHEMBL27902298 0.72 CYP2A6 (0.65) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL3137389 0.70 CYP2A6 (0.62) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL12277498 0.70 CYP2A6 (0.62) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL12259995 0.70 CYP2A6 (0.62) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL17684970 0.69 CYP2A6 (0.56) KDM4EMAPTCYP1A2CYP2A6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed